It was thus proposed that interfering with ligand–receptor (NT-3/TrkC) interaction, either by gene silencing or the use of a blocking antibody, is associated in different animal models with the inhibition of tumor growth and metastasis [12]. Here, NTRK3 is linked to neoplasm.